{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:37:10Z","timestamp":1787755030002,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The diagnosis of a fragility fracture represents an important intervention event for the initiation of medical osteoporosis treatments. However, it is unclear if osteoporosis medications increase the risk of nonunion if administered in the setting of acute fracture. The purpose of the present study was to investigate whether bisphosphonates or selective estrogen receptor modulators\/hormone replacement therapy (SERM\/HRT) are associated with nonunion following fracture in a Medicare population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective analysis of Medicare claims from 2016 to 2019 was performed to identify patients \u226565 years of age who had a surgically treated long-bone fracture as identified with Current Procedural Terminology (CPT) codes and International Classification of Diseases, 10th Revision (ICD-10) codes. Successive claims were linked for each beneficiary through 1 year following the fracture to determine fracture union status. Multivariable logistic regression models were specified to identify the association between medications and fracture union status while controlling for age, sex, race, Charlson Comorbidity Index (CCI), and fracture type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 111,343 included fractures, 10,452 (9.4%) were associated with a diagnosis of nonunion within 1 year. The nonunion group was younger (79.8 \u00b1 8.3 versus 80.6 \u00b1 8.4 years; p &lt; 0.001), more likely to be White (92.4% versus 90.9%; p &lt; 0.001), and more likely to have a CCI of \u22652 (50.9% versus 49.4%; p &lt; 0.001). Bisphosphonate use was more common in the nonunion group (12.2% versus 11.4%; p = 0.017). When controlling for race, age, sex, and CCI, neither bisphosphonates (OR, 1.06 [95% CI, 0.99 to 1.12]; p = 0.101) nor SERM\/HRT (OR, 1.13 [0.93 to 1.36]; p = 0.218) were associated with nonunion. Bisphosphonate use within 90 days post-fracture was not significantly associated with nonunion (OR, 0.94 [95% CI, 0.86 to 1.03]; p = 0.175), and the timing of medication administration did not influence fracture union status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The rate of nonunion after operatively treated long-bone fractures was 9.4%. In this cohort, use of a bisphosphonate or SERM\/HRT was not associated with fracture union status at 1 year. Orthopaedic surgeons should not withhold or delay initiating medical therapies for osteoporosis in the setting of acute fracture out of concern for nonunion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      Prognostic\n                      <jats:underline>Level III<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.22.01127","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T14:58:50Z","timestamp":1675868330000},"page":"549-555","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["No Increased Risk of Nonunion with Bisphosphonate Use in a Medicare Claims Cohort Following Operatively Treated Long-Bone Fractures"],"prefix":"10.2106","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8305-6306","authenticated-orcid":false,"given":"Tyler J.","family":"Thorne","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillia","family":"Steffenson","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2985-2445","authenticated-orcid":false,"given":"Dillon C.","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4499-6669","authenticated-orcid":false,"given":"Lucas S.","family":"Marchand","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1808-3425","authenticated-orcid":false,"given":"Brook I.","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8269-3925","authenticated-orcid":false,"given":"Justin M.","family":"Haller","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"issue":"1","key":"bib1-20250430","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12891-021-03960-z","article-title":"Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario","volume":"22","author":"Brown","year":"2021","journal-title":"BMC Musculoskelet Disord."},{"issue":"9","key":"bib2-20250430","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a116756","article-title":"Population-based study of survival after osteoporotic fractures","volume":"137","author":"Cooper","year":"1993","journal-title":"American Journal of Epidemiology."},{"issue":"5","key":"bib3-20250430","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.2009.50","article-title":"Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women","volume":"301","author":"Bliuc","year":"2009","journal-title":"JAMA."},{"issue":"4","key":"bib4-20250430","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis","volume":"15","author":"Klotzbuecher","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"2","key":"bib5-20250430","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S8756-3282(95)00150-6","article-title":"A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders","volume":"17","author":"Murakami","year":"1995","journal-title":"Bone."},{"issue":"6","key":"bib6-20250430","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1359\/jbmr.070318","article-title":"Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair","volume":"22","author":"Amanat","year":"2007","journal-title":"J Bone Miner Res."},{"issue":"Suppl 7","key":"bib7-20250430","first-page":"S53","article-title":"Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone","volume":"5","author":"Goodship","year":"1994","journal-title":"Ann Oncol."},{"issue":"4","key":"bib8-20250430","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib","volume":"15","author":"Mashiba","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"2","key":"bib9-20250430","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcot.2016.01.003","article-title":"The effect of vitamin D and bisphosphonate on fracture healing: An experimental study","volume":"7","author":"Aydo\u011fan","year":"2016","journal-title":"Journal of Clinical Orthopaedics and Trauma."},{"issue":"4","key":"bib10-20250430","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jhsa.2008.12.011","article-title":"Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy","volume":"34","author":"Rozental","year":"2009","journal-title":"The Journal of Hand Surgery."},{"issue":"6","key":"bib11-20250430","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00198-008-0759-z","article-title":"The relation between bisphosphonate use and non-union of fractures of the humerus in older adults","volume":"20","author":"Solomon","year":"2009","journal-title":"Osteoporos Int."},{"issue":"5","key":"bib12-20250430","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cjtee.2016.07.001","article-title":"Treatment of osteoporotic intertrochanteric fractures by zoledronic acid injection combined with proximal femoral nail anti-rotation","volume":"19","author":"Li","year":"2016","journal-title":"Chinese Journal of Traumatology."},{"issue":"7","key":"bib13-20250430","first-page":"956","article-title":"Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures?","volume":"94-B","author":"Kim","year":"2012","journal-title":"The Journal of Bone and Joint Surgery. British volume."},{"issue":"1","key":"bib14-20250430","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/2229-516X.198523","article-title":"Effect of zoledronic acid on fracture healing in osteoporotic patients with intertrochanteric fractures","volume":"7","author":"Hayer","year":"2017","journal-title":"International Journal of Applied and Basic Medical Research."},{"issue":"4","key":"bib15-20250430","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4055\/cios.2016.8.4.437","article-title":"Influence of Early Bisphosphonate Administration for Fracture Healing in Patients with Osteoporotic Proximal Humerus Fractures","volume":"8","author":"Seo","year":"2016","journal-title":"Clin Orthop Surg."},{"issue":"3","key":"bib16-20250430","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5005\/jp-journals-10080-1439","article-title":"Effects of Zoledronic Acid Treatment on Fracture Healing, Morbidity and Mortality in Elderly Patients with Osteoporotic Hip Fractures","volume":"14","author":"Gulcu","year":"2020","journal-title":"Strategies in Trauma and Limb Reconstruction."},{"issue":"11","key":"bib17-20250430","doi-asserted-by":"crossref","first-page":"e162775","DOI":"10.1001\/jamasurg.2016.2775","article-title":"Epidemiology of Fracture Nonunion in 18 Human Bones","volume":"151","author":"Zura","year":"2016","journal-title":"JAMA Surg."},{"key":"bib18-20250430","doi-asserted-by":"crossref","first-page":"101117","DOI":"10.1016\/j.bonr.2021.101117","article-title":"The effect of osteoporosis and its treatment on fracture healing a systematic review of animal and clinical studies","volume":"15","author":"Gorter","year":"2021","journal-title":"Bone Reports."},{"issue":"1","key":"bib19-20250430","doi-asserted-by":"crossref","first-page":"20942","DOI":"10.1038\/s41598-021-00199-5","article-title":"Use of the p-values as a size-dependent function to address practical differences when analyzing large datasets","volume":"11","author":"G\u00f3mez-de-Mariscal","year":"2021","journal-title":"Sci Rep."},{"issue":"1","key":"bib20-20250430","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jbmr.3877","article-title":"Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition","volume":"35","author":"Conley","year":"2020","journal-title":"J Bone Miner Res."},{"issue":"8","key":"bib21-20250430","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/jbmr.2888","article-title":"A Crisis in the Treatment of Osteoporosis","volume":"31","author":"Khosla","year":"2016","journal-title":"J Bone Miner Res."},{"issue":"22","key":"bib22-20250430","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1001\/archinte.1997.00440430099012","article-title":"Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial","volume":"157","author":"Ensrud","year":"1997","journal-title":"Archives of Internal Medicine."},{"issue":"1","key":"bib23-20250430","doi-asserted-by":"crossref","first-page":"e0115091","DOI":"10.1371\/journal.pone.0115091","article-title":"Patterns of bisphosphonates utilization in patients under age 45 in a large cohort of commercial insurance beneficiaries in the United States","volume":"10","author":"Xie","year":"2015","journal-title":"PLoS One."},{"issue":"1","key":"bib24-20250430","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.2106\/JBJS.RVW.O.00008","article-title":"Biological Risk Factors for Nonunion of Bone Fracture","volume":"4","author":"Zura","year":"2016","journal-title":"JBJS Rev."},{"issue":"18","key":"bib25-20250430","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med."},{"issue":"6","key":"bib26-20250430","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00774-013-0461-x","article-title":"The SERM raloxifene improves diaphyseal fracture healing in mice","volume":"31","author":"Spiro","year":"2013","journal-title":"J Bone Miner Metab."},{"issue":"4","key":"bib27-20250430","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/17453674.2017.1321351","article-title":"The risk of non-union per fracture: current myths and revised figures from a population of over 4 million adults","volume":"88","author":"Mills","year":"2017","journal-title":"Acta Orthopaedica."},{"key":"bib28-20250430","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bone.2016.11.006","article-title":"Bone fracture nonunion rate decreases with increasing age: A prospective inception cohort study","volume":"95","author":"Zura","year":"2017","journal-title":"Bone."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.22.01127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:36:27Z","timestamp":1787751387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.22.01127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.22.01127","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]}}}